Showing results (1851-1860 of 2,796) with videos related to
Sort By:
Pageof 280
Cytotherapy|December 30, 2019
Multi-laboratory assay for harmonization of enumeration of viable CD34+ and CD45+ cells in frozen cord blood unitsDiane Fournier, Antoine Lewin, Carl Simard, et al.Cytotherapy|March 23, 2020
Accelerating the development of innovative cellular therapy products for the treatment of cancerMark D Stewart, Anne Keane, Lisa H Butterfield, et al.Cytotherapy|October 23, 2020
Immunomodulatory effects of cytokine-induced expansion of cytotoxic lymphocytes in a mouse model of lupus-like diseaseSeth D Reighard, Durga Krishnamurthy, Hilal Cevik, et al.Cytotherapy|October 18, 2020
Development of an optimized closed and semi-automatic protocol for Good Manufacturing Practice manufacturing of tumor-infiltrating lymphocytes in a hospital environmentPhilippe O Gannon, Alexandre Harari, Aymeric Auger, et al.Cytotherapy|March 31, 2018
Regulatory perspective on in vitro potency assays for human T cells used in anti-tumor immunotherapyCharlotte de Wolf, Marja van de Bovenkamp, Marcel HoefnagelCytotherapy|December 1, 2018
Closed loop bioreactor system for the ex vivo expansion of human T cellsMatthew Li, Ling-Yee Chin, Syukri Shukor, et al.Cytotherapy|January 19, 2019
T-cell receptor gene-modified cells: past promises, present methodologies and future challengesRita Tendeiro Rego, Emma C Morris, Mark W LowdellCytotherapy|November 1, 2019
Automated Good Manufacturing Practice-compliant generation of human monocyte-derived dendritic cells from a complete apheresis product using a hollow-fiber bioreactor system overcomes a major hurdle in the manufacture of dendritic cells for cancer vaccinesUgur Uslu, Michael Erdmann, Manuel Wiesinger, et al.Cytotherapy|December 2, 2020
Human umbilical cord mesenchymal stromal cells as an adjunct therapy with therapeutic hypothermia in a piglet model of perinatal asphyxiaNicola J Robertson, Christopher Meehan, Kathryn A Martinello, et al.Cytotherapy|February 17, 2018
The simultaneous isolation of multiple high and low frequent T-cell populations from donor peripheral blood mononuclear cells using the major histocompatibility complex I-Streptamer isolation technologyMarthe C J Roex, Lois Hageman, Matthias T Heemskerk, et al.Pageof 280